Atorvastatin Calcium
Product Images NDC 71610-170

8 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71610-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71610 0168 15

71610 0168 15
Label for Atorvastatin Calcium 40 mg tablets, packaged in a quantity of 15. The label includes the NDC number 71610-0168-15 and storage instructions to keep the product between 20-25 degrees Celsius. It is labeled for prescription use (RX Only) and lists Aphena Pharma Solutions - Tennessee, LLC as the labeler.*
FDA Label Image

Bottle Label 10 mg (71610 0169 60)

Bottle Label 10 mg (71610 0169 60)
Label for Atorvastatin Calcium 10 mg tablets, packaged in a container of 90 tablets. The label includes storage instructions and notes that the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC. Manufactured by ScieGen Pharmaceuticals Inc. in Hauppauge, NY. The label indicates the product is prescription only (RX Only).*
FDA Label Image

Bottle Label 80 mg (71610 0170 45)

Bottle Label 80 mg (71610 0170 45)
Label for Atorvastatin Calcium 80 mg tablets, containing 45 tablets per bottle. The label includes storage instructions and manufacturer details indicating the product is made by ScieGen Pharmaceuticals Inc. and repackaged by Aphena Pharma Solutions - Tennessee, LLC. It specifies that the product is for prescription use only.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line chart comparing the cumulative incidence (%) over time (years) between Atorvastatin and placebo groups. The graph shows two lines: a solid line for Atorvastatin and a dashed line for placebo, demonstrating a difference in incidence rates over a period of up to 3.5 years. Statistical data including hazard ratio (HR=0.64) and p-value (p=0.0005) are displayed.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line chart comparing cumulative hazard percentages over a four-year follow-up period between a placebo group and an atorvastatin group. The chart shows time to first primary endpoint on the x-axis (years) and cumulative hazard on the y-axis (%), with atorvastatin consistently showing lower hazard than placebo.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A Kaplan-Meier curve chart comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, while the y-axis shows the percentage of subjects experiencing the event. The chart includes a hazard ratio (HR) of 0.78 with a confidence interval and a p-value of 0.0002, indicating statistical analysis results.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium showing its molecular arrangement with functional groups and ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.